NCT06325748 2026-02-12SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSSenti BiosciencesPhase 1 Active not recruiting21 enrolled
NCT01840566 2025-12-03High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Active not recruiting17 enrolled